0 Table of Contents |
1 Home |
2 2016 CDC Guideline - Profiles |
3 2016 CDC Guideline - Terminology |
4 2016 CDC Guideline - Examples |
5 2016 CDC Guideline - Documentation |
5.1 2016 CDC Guideline - Implementation Documentation |
5.2 2016 CDC Guideline - Integration Documentation |
5.3 2016 CDC Guideline - Process Documentation |
5.4 2016 CDC Guideline - Service Documentation |
6 2016 CDC Guideline - Downloads |
7 2016 CDC Guideline - Quick Start |
8 Conformance Resource Registry |
9 Chronic Pain Decision Documentation |
10 2016 CDC Guideline Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration |
10.1 OpioidCDS Recommendation 01 - CQL Source |
11 2016 CDC Guideline Recommendation #2 - Opioid Therapy Goals Discussion |
11.1 OpioidCDS Recommendation 02 - CQL Source |
12 2016 CDC Guideline Recommendation #3 - Opioid Therapy Risk/Benefit Discussion |
12.1 OpioidCDS Recommendation 03 - CQL Source |
13 2016 CDC Guideline Recommendation #4 Order Sign Variation - Opioid Immediate Release Form When Starting Opioid Therapy |
13.1 OpioidCDS Recommendation 04 Order Sign - CQL Source |
14 2016 CDC Guideline Recommendation #4 Patient View Variation - Opioid Immediate Release Form When Starting Opioid Therapy |
14.1 OpioidCDS Recommendation 04 Patient View - CQL Source |
15 2016 CDC Guideline Recommendation #5 - Lowest Effective Dose |
15.1 OpioidCDS Recommendation 05 - CQL Source |
16 2016 CDC Guideline Recommendation #6 - Prescribe Lowest Effective Dose and Duration |
16.1 OpioidCDS Recommendation 06 - CQL Source |
17 2016 CDC Guideline Recommendation #7 - Opioid Therapy Risk Assessment |
17.1 2016 CDC Guideline OpioidCDS Recommendation 07 - CQL Source |
18 2016 CDC Guideline Recommendation #8 - Naloxone Consideration |
18.1 OpioidCDS Recommendation 08 - CQL Source |
19 2016 CDC Guideline Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions |
19.1 OpioidCDS Recommendation 09 - CQL Source |
20 2016 CDC Guideline Recommendation #10 Order Sign Variation - Urine Drug Testing |
20.1 OpioidCDS Recommendation 10 Order Sign - CQL Source |
21 2016 CDC Guideline Recommendation #10 Patient View Variation - Urine Drug Testing |
21.1 OpioidCDS Recommendation 10 Patient View - CQL Source |
22 2016 CDC Guideline Recommendation #11 Order Select Variation - Concurrent Use of Opioids and Benzodiazepines |
22.1 OpioidCDS Recommendation 11 Order Select - CQL Source |
23 2016 CDC Guideline Recommendation #11 Patient View Variation - Concurrent Use of Opioids and Benzodiazepines |
23.1 OpioidCDS Recommendation 11 Patient View - CQL Source |
24 2016 CDC Guideline Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder |
24.1 OpioidCDS Recommendation 12 (patient-view) - CQL Source |
25 License and Legal Terms |
26 Artifacts Summary |
26.1 HelloWorld |
26.2 HelloWorldPatientView |
26.3 CDCMMEClinicalConversionFactors |
26.4 OpioidCDSRoutines |
26.5 OpioidCDSCommon |
26.6 OpioidCDSCommonConfig |
26.7 OpioidLogicMK2020 |
26.8 OpioidData2020 |
26.9 OpioidLogicMK2019 |
26.10 OpioidData2019 |
26.11 FHIRHelpers |
26.12 FHIRModelInfo |
26.13 OpioidCDSREC10CommonLibrary |
26.14 OpioidCDSREC01Library |
26.15 OpioidCDSREC01Library |
26.16 OpioidCDSREC03Library |
26.17 OpioidCDSREC04Library |
26.18 OpioidCDSREC04PatientViewLibrary |
26.19 OpioidCDSREC05Library |
26.20 OpioidCDSREC06Library |
26.21 OpioidCDSREC07Library |
26.22 OpioidCDSREC08Library |
26.23 OpioidCDSREC09Library |
26.24 OpioidCDSREC10Library |
26.25 OpioidCDSREC10PatientViewLibrary |
26.26 OpioidCDSREC11Library |
26.27 OpioidCDSREC11PatientViewLibrary |
26.28 OpioidCDSREC12PatientViewLibrary |
26.29 OpioidRiskAssessmentActivityDefinition |
26.30 OpioidUrineScreeningActivityDefinition |
26.31 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #1 |
26.31.1 Library |
26.32 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #2 |
26.32.1 Library |
26.33 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #3 |
26.33.1 Library |
26.34 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #4 (patient view) |
26.34.1 Library |
26.35 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #4 |
26.35.1 Library |
26.36 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #5 |
26.36.1 Library |
26.37 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #6 |
26.37.1 Library |
26.38 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #7 |
26.38.1 Library |
26.39 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #8 (order-sign) |
26.39.1 Library |
26.40 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #8 |
26.40.1 Library |
26.41 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #9 |
26.41.1 Library |
26.42 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 (order-sign) |
26.42.1 Library |
26.43 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 (patient-view) |
26.43.1 Library |
26.44 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #10 |
26.44.1 Library |
26.45 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #11 (patient-view) |
26.45.1 Library |
26.46 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #11 |
26.46.1 Library |
26.47 PlanDefinition - CDC 2016 Opioid Prescribing Guideline Recommendation #12 (patient-view) |
26.47.1 Library |
26.48 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4 |
26.49 Morphine Milligram Equivalent (MME) Calculator for FHIR R4 |
26.50 Opioid Management Terminology Knowledge Data |
26.51 Opioid Management Terminology Knowledge Logic |
26.52 CDC_CarePlan |
26.53 CDC_MedicationRequest |
26.54 CDC_Observation |
26.55 CDC_RequestGroup |
26.56 CDC-ValueSet |
26.57 DataDateRollerExtension |
26.58 OpioidCDSIndicator |
26.59 CDC 2016 Opioid Guidance Clinical Focus Extension |
26.60 CDC 2016 Opioid Guidance Data Element Extension |
26.61 CDC 2016 Opioid Guidance exclusion Criteria Extension |
26.62 CDC 2016 Opioid Guidance Inclusion Criteria Extension |
26.63 Action_indicator |
26.64 benzodiazepine medications |
26.65 Buprenorphine and Methadone medications |
26.66 CDC malignant cancer conditions |
26.67 Cocaine urine drug screening tests |
26.68 ValueSet - Condition Clinical Status Active |
26.69 ValueSet - Encounter Diagnosis Condition Categories |
26.70 ValueSet - Problem List Condition Category |
26.71 ValueSet - US Core Health Concern Condition Category |
26.72 Conditions documenting substance misuse |
26.73 Conditions likely terminal for opioid prescribing |
26.74 Extended release opioid with ambulatory misuse potential |
26.75 Fentanyl-type medications |
26.76 Fentanyl-type urine drug screening tests |
26.77 General opiate urine drug screening tests |
26.78 ValueSet - Hospice Disposition |
26.79 Hospice Finding |
26.80 Hospice Procedure |
26.81 Limited life expectancy conditions |
26.82 ValueSet - Medication Request Category Community |
26.83 ValueSet - Medication Request Status Active |
26.84 naloxone medications |
26.85 Non-opioid drug urine screening |
26.86 Non-synthetic opioid medications |
26.87 ValueSet - Observation Category Laboratory |
26.88 ValueSet - Observation Category Procedure |
26.89 ValueSet - Office Visit |
26.90 Oncology specialty designations (NUCC) |
26.91 Opiate specific urine drug screening tests |
26.92 Opioid analgesics with ambulatory misuse potential |
26.93 Opioid counseling procedure |
26.94 Opioid drug urine screening |
26.95 Opioid misuse assessment procedure |
26.96 Opioid misuse disorders |
26.97 ValueSet - Opioid Indicator |
26.98 Pain management procedure |
26.99 Pain treatment plan |
26.100 PDMP data reviewed finding |
26.101 PDMP review procedure |
26.102 Phencyclidine urine drug screening tests |
26.103 Substance misuse behavioral counseling |
26.104 Synthetic opioid urine drug screening tests |
26.105 Therapies indicating end of life care |
26.106 Urine drug screening tests |
26.107 CodeSystem - CDC 2016 Opioid Indicator |
26.108 OpioidCDS CarePlan |
26.109 Cancer Diagnosis Condition |
26.110 End of Life Condition |
26.111 Terminal Condition |
26.112 Cancer Diagnosis Encounter |
26.113 Oncology Participant Encounter |
26.114 Recommendation 10 Patient View Context Encounter Example |
26.115 Recommendation 10 Patient View Prefetch Encounter Example |
26.116 Ambulatory Opioid MedicationDispense |
26.117 OpioidCDS MedicationRequest |
26.118 Ambulatory Opioid MedicationRequest |
26.119 Recommendation 10 Patient View Context MedicationRequest Example |
26.120 Recommendation 10 Patient View Prefetch MedicationRequest Example |
26.121 OpioidCDS Observation |
26.122 OpioidCDS Patient |
26.123 Recommendation 10 Patient View Prefetch Patient Example |
26.124 Oncology Specialist PractitionerRole |
26.125 OpioidCDS RequestGroup |
26.126 Palliative Care ServiceRequest |
26.127 CQFToolingDevice |